Ralph Tiedt,Christian Chatenay-Rivauday,Moriko Ito,Mikhail Akimov,Bin Peng,Ying Gong
申请号：
US15839964
公开号：
US20180098995A1
申请日:
2017.12.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to pharmaceutical products comprising a combination of (i) a MET inhibitor and (ii) an EGFR inhibitor, or a pharmaceutically acceptable salt thereof, respectively, or a prodrug thereof, which are jointly active in the treatment of proliferative diseases, corresponding pharmaceutical formulations, uses, methods, processes, commercial packages and related invention embodiments.
